Board of Scientific Counselors, Coordinating Center for Infectious Diseases (CCID), 56076 [E7-19403]
Download as PDF
<![CDATA[
56076
Federal Register / Vol. 72, No. 190 / Tuesday, October 2, 2007 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Advisory Committee on Immunization
Practices
Board of Scientific Counselors,
Coordinating Center for Infectious
Diseases (CCID)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
rmajette on PROD1PC64 with NOTICES
Times and Dates: 8 a.m.–6 p.m., October
24, 2007; 8 a.m.–5 p.m., October 25, 2007
Place: CDC, Tom Harkin Global
Communications Center, 1600 Clifton Road,
NE., Building 19, Kent ‘‘Oz’’ Nelson
Auditorium, Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The committee is charged with
advising the Director, CDC, on the
appropriate uses of immunizing agents. In
addition, under 42 U.S.C. 1396s, the
committee is mandated to establish and
periodically review and, as appropriate,
revise the list of vaccines for administration
to vaccine-eligible children through the
Vaccines for Children (VFC) program, along
with schedules regarding the appropriate
periodicity, dosage, and contraindications
applicable to the vaccines.
Matters To Be Discussed: The agenda will
include discussions on Influenza Vaccines;
Meningococcal Conjugate Vaccine;
Childhood and Adolescent Immunization
Schedule—2007; Immunization Schedule for
HIV-Infected Adults; Pediatric Use of
Pneumococcal Vaccines; Updates on
Combination Vaccines, Vaccine Supply and
Hepatitis B Vaccine; Immunization Safety
Office; HPV Vaccines; Rotavirus Vaccine; and
departmental updates. There may be possible
VFC voting on the Influenza and
Meningococcal Vaccines.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Tonica Gleaton, Immunization Services
Division, National Center for Immunization
and Respiratory Diseases, CDC, 1600 Clifton
Road, NE., (E–05), Atlanta, Georgia 30333,
Telephone (404) 639–8836, Fax (404) 639–
8905.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both the CDC and the Agency for Toxic
Substance and Disease Registry.
Dated: September 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–19393 Filed 10–1–07; 8:45 am]
BILLING CODE 4160–18–P
VerDate Aug<31>2005
15:35 Oct 01, 2007
Jkt 214001
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
aforementioned committee.
Times and Dates: 9 a.m.–5 p.m., October
31, 2007; 8:30 a.m.–3:30 p.m., November 1,
2007
Place: CDC, Building 19, 1600 Clifton
Road, NE., Atlanta, Georgia 30333.
Status: Open to the public, limited only by
the space available.
Purpose: The Board of Scientific
Counselors, Coordinating Center for
Infectious Diseases (CCID), provides advice
and guidance to the Director, CDC, and
Director, CCID, in the following areas:
program goals and objectives, strategies,
program organization and resources for
infectious disease prevention and control,
and program priorities.
Matters To Be Discussed: Agenda items
will include:
1. Breakout Group Discussions:
A. Laboratory Preparedness and
Sustainability, National Center for
Prevention, Detection, and Control of
Infectious Diseases.
B. Influenza Diagnostics Program, National
Center for Immunization, and Respiratory
Diseases (NCIRD).
C. Immunization Assessment and
Coverage, NCIRD.
D. Strategic Surveillance, National Center
for HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention.
E. Infectious Disease Ecology, National
Center for Zoonotic, Vector-Borne, and
Enteric Diseases.
2. Surveillance Systems.
3. CCID Updates.
4. Budget Updates.
Other agenda items include
announcements and introductions, follow-up
on actions recommended by the Board from
March 2007, consideration of future
directions, goals, and recommendations.
Agenda items are subject to change as
priorities dictate.
Written comments are welcome and should
be received by the contact person listed
below prior to the opening of the meeting.
Contact Person for More Information:
Harriette Lynch, Office of the Director, NCID,
CDC, Mailstop A–45, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, e-mail:
HLynch@cdc.gov, telephone 404/639–4035.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: September 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. E7–19403 Filed 10–1–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. 2007N–0014]
Agency Information Collection
Activities; Announcement of Office of
Management and Budget Approval;
Submission of Petitions: Food
Additive, Color Additive (Including
Labeling), and Generally Recognized
as Safe Affirmation; Electronic
Submission Using Food and Drug
Administration Forms 3503 and 3504
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing
that a collection of information entitled
‘‘Submission of Petitions: Food
Additive, Color Additive (Including
Labeling), and Generally Recognized as
Safe Affirmation; Electronic Submission
Using Food and Drug Administration
Forms 3503 and 3504’’ has been
approved by the Office of Management
and Budget (OMB) under the Paperwork
Reduction Act of 1995.
FOR FURTHER INFORMATION CONTACT:
Jonna Capezzuto, Office of the Chief
Information Officer (HFA–250), Food
and Drug Administration, 5600 Fishers
Lane, Rockville, MD 20857, 301–827–
4659.
In the
Federal Register of April 25, 2007 (72
FR 20553), the agency announced that
the proposed information collection had
been submitted to OMB for review and
clearance under 44 U.S.C. 3507. An
agency may not conduct or sponsor, and
a person is not required to respond to,
a collection of information unless it
displays a currently valid OMB control
number. OMB has now approved the
information collection and has assigned
OMB control number 0910–0016. The
approval expires on August 31, 2010. A
copy of the supporting statement for this
information collection is available on
the Internet at https://www.fda.gov/
ohrms/dockets.
SUPPLEMENTARY INFORMATION:
E:\FR\FM\02OCN1.SGM
02OCN1
]]>Agencies
[Federal Register Volume 72, Number 190 (Tuesday, October 2, 2007)]
[Notices]
[Page 56076]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-19403]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, Coordinating Center for
Infectious Diseases (CCID)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting of the aforementioned
committee.
Times and Dates: 9 a.m.-5 p.m., October 31, 2007; 8:30 a.m.-3:30
p.m., November 1, 2007
Place: CDC, Building 19, 1600 Clifton Road, NE., Atlanta,
Georgia 30333.
Status: Open to the public, limited only by the space available.
Purpose: The Board of Scientific Counselors, Coordinating Center
for Infectious Diseases (CCID), provides advice and guidance to the
Director, CDC, and Director, CCID, in the following areas: program
goals and objectives, strategies, program organization and resources
for infectious disease prevention and control, and program
priorities.
Matters To Be Discussed: Agenda items will include:
1. Breakout Group Discussions:
A. Laboratory Preparedness and Sustainability, National Center
for Prevention, Detection, and Control of Infectious Diseases.
B. Influenza Diagnostics Program, National Center for
Immunization, and Respiratory Diseases (NCIRD).
C. Immunization Assessment and Coverage, NCIRD.
D. Strategic Surveillance, National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention.
E. Infectious Disease Ecology, National Center for Zoonotic,
Vector-Borne, and Enteric Diseases.
2. Surveillance Systems.
3. CCID Updates.
4. Budget Updates.
Other agenda items include announcements and introductions,
follow-up on actions recommended by the Board from March 2007,
consideration of future directions, goals, and recommendations.
Agenda items are subject to change as priorities dictate.
Written comments are welcome and should be received by the
contact person listed below prior to the opening of the meeting.
Contact Person for More Information: Harriette Lynch, Office of
the Director, NCID, CDC, Mailstop A-45, 1600 Clifton Road, NE.,
Atlanta, Georgia 30333, e-mail: HLynch@cdc.gov, telephone 404/639-
4035.
The Director, Management Analysis and Services Office has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention
and the Agency for Toxic Substances and Disease Registry.
Dated: September 26, 2007.
Elaine L. Baker,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. E7-19403 Filed 10-1-07; 8:45 am]
BILLING CODE 4163-18-P
